Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) (Parenthetical) - USD ($) $ in Thousands |
3 Months Ended | |
|---|---|---|
Mar. 31, 2026 |
Mar. 31, 2025 |
|
| Research and development expenses | $ 7,572 | $ 6,030 |
| General and administrative expenses | 4,261 | 4,324 |
| Change in fair value of tranche liability | 0 | 365 |
| Change in fair value of derivative liability | 0 | 1,229 |
| Interest expense | 0 | 1,443 |
| Loss on extinguishment and on issuance of convertible promissory notes | 0 | (186) |
| Related Party | ||
| Research and development expenses | 15 | 13 |
| General and administrative expenses | 73 | 151 |
| Change in fair value of tranche liability | 0 | 331 |
| Change in fair value of derivative liability | 0 | 1,165 |
| Interest expense | 0 | 1,384 |
| Loss on extinguishment and on issuance of convertible promissory notes | $ 0 | $ 169 |
| X | ||||||||||
- Definition Change in fair value of derivative liability. No definition available.
|
| X | ||||||||||
- Definition Change in fair value of tranche liability. No definition available.
|
| X | ||||||||||
- Definition Loss on extinguishment and on issuance of convertible promissory notes. No definition available.
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|